Skip to Content
Browse all medications
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Advanced
Phonetic
Search:
Drugs A-Z
Complete A - Z Drug Index
Drugs by Condition
Drugs by Class
Drug Side Effects
Drug Dosage
Pregnancy Warnings
Breastfeeding Information
International Drugs
Generic Drugs
Veterinary Drugs
Natural Products
Phonetic Search
Harvard Health Topics
Medical Encyclopedia
Pill Identifier
Interactions Checker
News / Alerts
FDA Medwatch Drug Alerts
FDA Labeling Changes
Daily MedNews for Consumers
Pharmaceutical Industry News
Clinical Trial News
New Drug Approvals
New Drug Applications (Pipeline)
Get News via RSS
Get News via Twitter
Drugs.com Blog
Health Professionals
Professional Resource Center
FDA Prescribing Information
AHFS DI Monographs
A-Z Drug Facts for the Professional
Drug Interactions Checker
Patient CareNotes for the Professional
Natural Products Database
Medical Conferences
Pharmaceutical Company Directory
Medical Dictionary
Phonetic Drug Search
Community
Ask Medical Questions
Join Support Groups
Forum - Discussion Boards
Mednotes
Apps
Home
›
News
›
Pharma Industry News
› Archive
Pharmaceutical Industry News Archive
Get news
By email
or subscribe to our
News feeds
.
All News
Consumer
Pharma
New Drugs
Pipeline
Clinical Trials
June 2007
June 1
Bristol-Myers Squibb Awards Immunicon New Research Services Agreement for Oncology Biomarker Development
Isogenica Enters into Research and License Agreement with Wyeth
Mylan Wins Omeprazole Patent Litigation
Jazz Pharmaceuticals, Inc. Announces Initial Public Offering
Nventa Consolidates Offices Into San Diego
Black Horse Capital Opposes the Strategic Direction of Cypress Bioscience
MOLOGEN AG Sells Spanish Subsidiary
Revision - Decision Fails Patients with Transfusion-Dependent Anemia
Termination of Development of Fixed Dose Combination Product of Actos + TAK-536
AstraZeneca’s Prilosec Patents Upheld By Court
Barr Confirms Decision in Azithromycin Inventorship Suit
Pharmaceutical Blog Chatter Continues About Dr. Steven Nissen’s Avandia Revelations, Most Bloggers Refute
Transition Therapeutics Acquires All Remaining Shares of NeuroMedix Inc.
ImpaxX Announces Decision on Generic Prilosec Litigation
June 4
Bayer Schering Pharma AG Will Terminate Registration With the U.S. SEC
Final Data from a Phase 2 Trial Presented at ASCO Specifies Dose-dependent Activity of Adecatumumab (MT201)
AstraZeneca Acquires Biologics Manufacturing Facility in Canada
Cell Genesys and Medarex Report Follow-Up Data From a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
New Data Evaluating Sutent, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer
GlaxoSmithKline Reports Positive New Data on Tykerb at the 2007 ASCO Annual Meeting
Phase III Ixabepilone Study Demonstrated Significant Improvement in Progression-Free Survival in Patients With Advanced Metastatic Breast Cancer
Telik Announces Top-Line Results of TELCYTA ASSIST-2 Trial
Telik Reports Results of TELCYTA ASSIST-1 Trial
Telik Reports Results of TELCYTA Assist-3 Trial
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac Weekly
DTC Advertising Improvements Observed In Two New Reports
FDA Announces New Advisory Committee to Address Risk Communication
June 5
Neurogen Announces Continuing Preclinical and Clinical Development Work and Conclusion of Research Component of Collaboration for Investigational Pain Drug
APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection
Eurand and GSK Reach Development Milestone
Telik Announces Clinical Hold on TELCYTA Trials
Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company Focused on Kidney Disease Care
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Valeant Pharmaceuticals Agrees to Sell Manufacturing Facilities in Basel, Switzerland and Humacao, Puerto Rico
Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.
Mylan Wins Its Amlodipine Case With Pfizer
June 6
GlaxoSmithKline Response to New England Journal of Medicine Editorials
CRO Company Merger; A First for China's Drug Development Contract Research Organization Industry
VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
AstraZeneca CFO to Join Goldman Sachs
WaferGen Completes Merger and Private Placement of $10.7 Million
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline
June 7
Takeda Revises Actos (pioglitazone HCl) Prescribing Label
American Diabetes Association Strongly Advises Patients Using Rosiglitazone to See Their Doctor
Roche Recalls Viracept Due to Chemical Impurity
Agilent Technologies Adds Strength to Its Life Science Business With Acquisition of Stratagene
Intertek Acquires QTI Laboratory
Forbion Announces Successful Exit from Alantos Pharmaceuticals
Genzyme to Build New Biomanufacturing Plant to Support Growth of Thymoglobulin
Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa Patents
June 8
Radiant Research Acquired by New Ownership Group
Johnson & Johnson Highlights Growth Strategies for Pharmaceutical and Consumer Businesses
Schering-Plough and Bayer Healthcare Announce Availability of ZETIA in Japan, the First Cholesterol-Lowering Agent With a Novel Mechanism of Action Approved in Japan in 18 Years
On the Launch and Measures for Proper Use of the Anti-Cancer Agent Avastin
Renovis Announces Achievement of Milestones in VR1 Collaboration with Pfizer Inc.
Pharma Blogs This Week: Hot & Heavy Congressional Committee Hearings, DTC Study Shows No Effect on Pricing, and Another Pharma CFO Bites the Dust
FDA Science Board to Meet on June 14
June 11
ZARS, Inc. Files Registration Statement for Initial Public Offering
Announcement of the Launch of the Selective COX-2 Inhibitor Celecox Tablets in Japan
Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
Archemix and Merck KGaA Sign Strategic Alliance
AMRI Receives Milestone Payment From Licensing Agreement with Bristol-Myers Squibb
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Merck Signs Strategic Alliance With Archemix
Pediatric Inhaled Corticosteroid Asthma Medication Features New Dose Counters to Help Track Usage
Barr Announces Withdrawal of Zyprexa Zydis Patent Litigation
Teva Receives Favorable Court Decision Regarding Generic Lotrel; Novartis' Motion for Preliminary Injunction Denied
US Court Allows Teva to Resume US Sales of Its Generic Version of Lotrel
Athersys Raises $65 Million in Concurrent Reverse Merger and Private Equity Offering
U.S. Department of Justice Investigation of Bristol-Myers Squibb in Proposed Plavix Patent Settlement Is Resolved
June 12
alli - The OTC Weight Loss Product - On Shelves Nationwide Later This Week
Vical Receives $6 Million Grant From NIH to Advance RapidResponse DNA Vaccine Platform
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
Kissei and Eisai sign a License Agreement to Develop and Commercialize Glufast, A Rapid-acting Insulin Secretagogue in 10 Asian Countries
China Biopharma Signed LOI to Acquire All the Interest of a Chinese Regional Pharmaceutical Distribution Company
Artes Medical Forms New Subsidiary to Commercially Develop and License Medical Applications of Its Microsphere Technology
Repligen Reports Ruling on Sanctions Motion Against ImClone
June 13
Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
New Survey Shows Product Liability Litigation May Jeopardize Treatment Outcomes for People with Severe Mental Illnesses
American Oriental Bioengineering Enters Into a Letter-of-Intent to Acquire Established Plant Based Pharmaceutical Company
Reps. Hinchey & Stupak: FDA's Bond With Drug Industry Is As Strong As Ever
Accentia Biopharmaceuticals' Majority-Owned Subsidiary, Biovest, Receives Request From the Independent Data Monitoring Committee to Conduct Interim Analysis of Anti-Cancer Vaccine, BiovaxID
Health Care Plans and Consumer Groups Unite and Call on Legislature to Pass Rx Gift Disclosure Law
June 14
Interpublic Announces Development in SEC Investigation
Charles River Laboratories Completes Chinese Joint Venture
Canadian Levofloxacin Patent Upheld by Federal Appeal Court
Cordis Corporation Resolves Corporate Warning Letter
June 18
NicOx Provides an Update on NCX 4016
Geron Increases Stake in TA Therapeutics Joint Venture
FDA Converts Telcyta Full Clinical Hold to Partial Hold
GlaxoSmithKline Expects to Launch Up to Five Major New Medicines for Oncology in Next Three Years
Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Development Strategy
Nabi Biopharmaceuticals Announces Creation of Biologics Business Unit & Provides Strategic Updates
Merck & Co. Ordered to Pay Attorneys' Fees, Costs Following Vioxx Consumer Fraud Finding
The Public is Doubtful that Strengthening the FDA's Oversight of the Prescription Drug Industry Will Make a Difference
June 19
Roche Acquires NimbleGen to Gain Entry Into High-Growth Research Microarrray Market
Regulatory Cooperation Expanded
Verispan Reports: Biotech Companies Cut Sales Forces, but Managed Care Execs Want More Contact
Bayer Raises Guidance for 2007 and 2009
Diamyd Continues Invalidated Study
ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
Safety Measures for Oseltamivir Phosphate and Chugai's Future Approach
Impax Announces Lawsuit Related to Generic Version of Depakote ER
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
CuraGen to Close Pilot Manufacturing Plant
June 20
Shire In-Licenses Juvista (Human TGFbeta3) From Renovo
New Potential Treatment in Development for Patients Facing Heart Health Challenges
Heygood, Orr, Reyes & Bartolomei: $5.5 Million Award in First Federal Fentanyl Patch Trial
Proteros biostructures Announce Successful Achievement of Milestone in Fragment-Based Protein Crystallography Collaboration
Texas Family Sues GlaxoSmithKline (GSK) Over Man's Heart Attack Death Following Avandia Use
Pfizer Discontinues Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer
Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non Small Cell Lung Cancer
Wyeth Responds to Verdict in Diet Drug Case
June 21
Cardinal Health Completes Initial Tender Offer for VIASYS Healthcare
WHI Study of Younger Postmenopausal Women Links Estrogen Therapy to Less Plaque in Arteries
PharmalLive Releases from Pipeline to Market 2007, an Exclusive Annual Special Report
June 22
Icagen Receives Notification from McNeil of Termination of Collaboration Agreement
Viragen Streamlines Research Focus and Halts Further Development of OVA System
Paion Reduces Number of Employees
Barr Receives Approval for Generic Vesanoid Capsules, 10 mg
European Medicines Agency Agrees on Action Plan Following the Recall of Viracept and Recommends Suspension of the Marketing Authorisation
Pharma Bloggers Discuss Delay in Maraviroc Approval, Removal of Provisions in Prescription Drug User Fee Act, Triumph for Plavix Marketers, and More on Sicko
June 25
AstraZeneca Announces Symbicort Is Now Available In The U.S.
European Medicines Agency Recommends Restricted Use for Piroxicam
Biodel Inc. Announces VIAject(TM) Data at Oral Presentation at the American Diabetes Association Meeting
New Data Show Patients Treated With Avandia (Rosiglitazone Maleate) Incurred Lower Medical Costs and Used Fewer Healthcare Resources When Compared to Patients Treated With Sulphonylureas
Roche and Toyama Chemical Enter Licensing Agreement to Develop Potential Breakthrough Drug to Treat Rheumatoid Arthritis
Apidra Improved A1C In People With Type 2 Diabetes When Added to Basal Insulin and Oral Antidiabetic Treatments (BOT)
Generex Biotechnology to Initiate Phase III Clinical Trial of Generex Oral-lyn in 2007 Third Quarter
Diabetes Patients Make Significant Gains in Disease Control; Still, Nearly Half Fail to Reach ADA Treatment Goals
Coalition Urges American Medical Association to Halt Sale of Physician Data to Pharmaceutical Marketing Firms
New Findings Show Half of Americans Surveyed Importing Drugs without a Prescription
U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust Lawsuits
June 26
Ventana Advises Shareholders to Defer Taking Any Action in Response to Roche Offer
UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for Multiple Sclerosis
Encysive Pharmaceuticals Appoints New Chief Executive and Announces Restructuring of Company Operations
Pharma ChemOutsourcing Conference Posts Attendee List for September Custom Synthesis Blockbuster Show in New Jersey
Commonly Prescribed Antidepressants Associated with Lower Bone Density in Older Men and Women
NextBio Announces License Agreement with Genzyme
Wyeth Licenses Drug Targets from Osteoporosis Collaboration with Galapagos
Abbott and Genentech Announce Global, Integrated Research, Development and Commercialization Collaboration in Oncology
Daiichi Sankyo Commences Patent Litigation Against Mylan in the United States
Organon Announces Acquisition of Kadmus Pharmaceuticals' FAAH Inhibitor Technology
Pharsight Invited to Present on Oncology Modeling and Simulation at AAPS National Biotechnology Conference on June 28, 2007
Biotechnology Council of New Jersey and Pennsylvania Bio to Host Seventh Annual Biosciences Symposium
Amgen Submits Testimony to House Ways & Means Committee
First Consulting Group Acquires Zorch, Inc.
Clinquest Takes Stake in Enceladus
Physicians Favor a DTC Moratorium More Strongly Than Consumers, though Both Groups Cite Public Safety as the Key Benefit, according to New TNS Healthcare Research
June 27
inVentiv Health to Acquire AWAC, Leader in Providing Medical Cost Containment Services to Payors
inVentiv Health to Acquire Chandler Chicco Agency
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
Cardinal Health Reaffirms Fiscal 2008 Outlook; Raises Long-Term Profit Goals
Vasogen Reports on Outcome of FDA Meeting
Vermont Attorney General Sorrell Releases Pharmaceutical Company Report
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
Biogen Idec Announces Preliminary Results of Its Modified ''Dutch Auction'' Tender Offer
Roche Commences Tender Offer for Ventana for $75 Per Share in Cash
Update on Migenix Agreement with Schering-Plough for Hepatitis C Virus Treatment
VASTox Announces Significant Progress in Pharmaceutical Services Business
Guideline and Med Ad News Host Panel to Discuss Issues Surrounding Patient Compliance
MichBio Announces Its 2007 Expo; Bio CEO to be Keynote Speaker
Spherix Signs Definitive Agreement for Sale of Information Subsidiary
June 28
Pharsight Preferred Stockholders Elect to Convert Preferred Shares Into Common Stock
Materia Licenses Metathesis Catalyst Platform to Eisai
Pfizer Board of Directors to Initiate Face-to-Face Meetings with Company's Institutional Investors on Corporate Governance Policies and Practices
Isotechnika Will Be Represented at the Canadian Dermatology Annual Conference
Bespak plc Exubera Update
The General Public Supports Breaking Drug Patents To Ensure Access To HIV/AIDS Drugs In Poorer Countries
Lawmakers Praise Committee Passage of Biologics Legislation
Bioscience Leaders Discuss Strategies to Propel Industry, Innovations Throughout Southern California
Cardinal Health Completes Subsequent Tender Offer for VIASYS Healthcare
Thallion Announces Sale of Majority Stake in Caprion Proteomics to Great Point Partners
June 29
Genmab Regains Rights to HuMax-CD4
Lorus Therapeutics Announces Receipt of Court Approval for Proposed Plan of Arrangement
Prescription Access Litigation: Federal Judge Allows Zyprexa Class Action to Go Forward
Urigen N.A., Inc. Completes Shareholder Meeting
Karo Bio Announces Delay in KB5359 Development
Yet Another Pfizer Whistleblower Comes Forth Through Blogs, CME Criticism Continues, and Dr. Rost Gains Access to Astrazeneca Ethics Violation Website
The International Society for Medical Publication Professionals (ISMPP) Publishes Position Paper on the Role of the Professional Medical Writer
Combination of Sartorius Biotech Division and Stedim Completed
Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer
RAPS Holds Japan Seminar, High-Ranking Officials Participate
Pharmaceutical Industry News Archive
2012
January
,
February
2011
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2010
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2009
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2008
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2007
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2006
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2005
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2004
January
,
February
,
March
,
April
,
May
,
July
,
August
,
September
,
October
,
November
,
December
2003
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2002
January
,
April
,
May
,
June
,
August
,
September
,
October
,
November
,
December
More News Resources
FDA Medwatch Drug Alerts
FDA Drug Safety Labeling Changes
Daily MedNews
Pharma Industry News
New Drug Approvals
New Drug Applications
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
Printable Version
Email
Recommend
Tweet
Save or Share
Search:
Sign In
or
Register
Username
Password
Forgot password?
FDA Consumer Updates
Primatene Mist With Chlorofluorocarbons No Longer Available After Dec. 31, 2011
HCG Diet Products are Illegal
Lock it Up: Medicine Safety in Your Home
Reducing Fever in Children: Safe Use of Acetaminophen
More FDA Updates...
Recently Approved
Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...
More...
Get Updates by Email
Email me:
FDA Medwatch Alerts
News Roundup
Daily
Weekly
Monthly
Email
(web3)